Provider
At HIMSS last week, Samsung announced a partnership with Travelers Insurance, Cedars-Sinai Medical Center, Bayer, and AppliedVR around using virtual reality for pain management.
A study of more than 500 children in rural India suggests that pairing SMS reminders with incentives more effectively produces desired health outcomes than the mobile reminders alone.
As the US government continues its push to make data more accessible and give patients control of their EHRs, private companies are stepping up hoping to fill the gap.
In January, Accenture completed its two-year contract with the Office of the National Coordinator for Health IT to create a white paper to advise the industry about implementing patient-generated health data projects.
A recently released analysis report from the Deloitte Center for Government Insights that examines the US’s current and proposed software as a medical device (SaMD) regulatory landscape, and includes suggestions on how the FDA’s pre-certification pilot program and other initiatives could better serve this fast-moving industry.
Patients at increased risk for atrial fibrillation wearing iRhythm’s Zio patch — a continuous ECG monitoring wearable — were more likely to have their atrial fibrillation diagnosed early and receive subsequent preventive care, according to one-year results from a late-breaking study presented at the American College of Cardiology’s annual meeting.
Medtronic has finally received FDA clearance for Guardian Connect, its smartphone-connected standalone CGM for patients who use multiple daily injections (MDI) for their insulin.
A team of researchers at Michigan State University have developed a smartphone-based blood pressure monitoring system that could be an alternative to the traditional blood pressure cuffs.
Duke University has launched a new Apple ResearchKit study, the MS Mosaic Study, aimed at using big data and patient insights to improve medical understanding of multiple sclerosis.
A new study, sponsored by the US Department of Veterans Affairs, applied wearable biosensors to post-acute heart failure patients and deployed FDA-cleared analytics from vendor physIQ to detect vital sign anomalies.